As of 2025-07-08, the Fair Value of Nabriva Therapeutics PLC (NBRV) is -117.81 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.42 USD, the upside of Nabriva Therapeutics PLC is -8,396.16%.
With the market price of 1.42 USD and our fair value calculation, Nabriva Therapeutics PLC (NBRV) is not a good investment. Investing in NBRV stocks now will result in a potential loss of 8,396.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -49.45 | -57.19 | - | - | -53.32 | |
| YoY growth | 28.83% | -15.64% | - | - | 6.60% | |
| Market Cap (mil) | 4.55 |
| P/E | |
| Forward P/E |
| EPS | -17.86 |
| Avg earnings growth rate | 6.60% |
| TTM earnings | -57.19 |